Big Changes Ahead For The Pharmaceutical Market

The composition of the Mexican drug market is forecast to change over the next five years. While patented drugs will remain the dominant contributor to the market, with a large market share by value of US$14.9bn by 2014, the generic drug segment will experience the highest compound annual growth rate (CAGR) - 30.6% between 2009 and 2014. Patented drugs will have a slower CAGR of 13.5% over this period.

To read the full article, please choose one of the following options: